The MARVIN Chatbots to Provide Information for Different Health Conditions
Recruiting now NCT05789901
Run by McGill University Health Centre/Research Institute of the McGill University Health Centre · for 14 and older · All sexes · accepts healthy volunteers
What this study is about
This research is a continuation of a usability study with the MARVIN chatbot. The investigators aim to adapt the MARVIN chatbot to open it to other health domains (e.g. breast cancer) and populations (e.g. pharmacists). Therefore, this protocol constitutes a master research protocol that will englobe different research projects with individual chatbots. The investigators adopt an adaptive platform trial design, which will allow flexibility in handling multiple interventions adapted to different populations while retaining the characteristics of a platform trial design allowing early withdrawal of ineffective trial arms based on interim data (implementation outcomes) and introduction of new trial arms.
Who can join (things the study team will check)
✅ You may be able to join if…
- being 14 years or older;
- being fluent in English and/or French;
- being able to understand the requirements of study participation and provide informed consent during the duration of the study;
- having access to a smartphone, tablet, or computer at home/at workplace;
- having access to an internet connection at home or data plan on their device.
✅ You may be able to join if…
- accept to use a Facebook Messenger-based Chatbot;
- accept to use or create a personal Facebook account;
- accept Facebook's privacy and data security policies.
🚫 You may not be able to join if…
- not meeting the inclusion criteria
- any reason, in the opinion of the investigator, which would make the candidate inappropriate for participation in an investigative study involving a chatbot (e.g., cognitive deficit)
Where this trial is running
- Centre hospitalier de l'Université de Montréal (CHUM), Montreal, Quebec, Canada
- McGill University Health Centre (MUHC), Montreal, Quebec, Canada
Who to contact
Bertrand Lebouché, MD · 514-843-2090 · bertrand.lebouche@mcgill.ca
It's completely normal to call and ask questions before deciding anything. Mention the study ID: NCT05789901.
Verify everything on the official ClinicalTrials.gov record. Page updated July 2026.